Group One Trading, L.P. Protalix Bio Therapeutics, Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.02 - $1.56 $33,298 - $50,927	-32,646 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.81 - $1.17 $484,299 - $699,543	-597,900 Reduced 94.82%	32,646 $35,000
Q4 2021 Feb 11, 2022	BUY	$0.81 - $1.33 $330,474 - $542,630	407,993 Added 183.32%	630,546 $524,000
Q3 2021 Nov 12, 2021	BUY	$1.31 - $1.87 $56,939 - $81,279	43,465 Added 24.27%	222,553 $296,000
Q2 2021 Aug 10, 2021	BUY	$1.86 - $6.22 $333,103 - $1.11 Million	179,088 New	179,088 $342,000
Q1 2021 May 12, 2021	SELL	$3.58 - $6.45 $180,002 - $324,306	-50,280 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.15 - $3.98 $158,382 - $200,114	50,280 New	50,280 $183,000
Q2 2020 Aug 13, 2020	SELL	$2.19 - $4.5 $13,072 - $26,860	-5,969 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.1 - $4.61 $1,470 - $3,227	700 Added 13.29%	5,969 $14,000
Q4 2019 Feb 10, 2020	BUY	$1.8 - $3.28 $9,484 - $17,282	5,269 New	5,269 $17,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.